FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
March 11, 2021 | Source: PRNewswire DUBLIN, March 11, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced…
Breaking News
03/11/2021
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
March 11, 2021 | Source: PRNewswire DUBLIN, March 11, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced…
|
|
02/05/2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021| Source: PRNewswire Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa (“nemvaleukin”, formerly referred to as…
|
|
01/26/2021
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
January 24, 2021 19:07 ET | Source: Junshi Biosciences Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
|
|
11/24/2020
Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma
Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
|
|
01/23/2020
AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University
January 23, 2020 (San Rafael, California)… AIM at Melanoma and AIM at Melanoma Research Foundation announce the opening of…
|
|
11/14/2019
AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University
AIM AT MELANOMA OPENS THIRD BRANCH OF FRESH FROZEN PRIMARY TISSUE BANK AT THE KNIGHT CANCER INSTITUTE AT OREGON…
|
|
09/09/2019
AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center
September 9, 2019 (San Rafael, California) AIM at Melanoma announces the grand opening of the second branch of the International…
|
|
04/04/2019
AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center
April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
|
|
11/13/2018
Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
|
|
11/13/2018
Melanoma Legislation: Progress Report
The facts are straightforward: Indoor tanning before 18 years of age increases one’s risk of melanoma by 85%,1 and the…
|
Recent Posts
Dec. 12, 2024
Navigating Melanoma Together: 2024 Podcast Wrap-Up
Dec. 10, 2024
Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel
Dec. 09, 2024
Managing Melanoma During the Holiday Season
Dec. 05, 2024
Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship
Dec. 03, 2024